Also in this playlist...
This transcript is automatically generated
Well no rivalry between Bayer Tylenol on doing what boys love it he's a -- Condon the company which -- worked on the Tylenol brand is lovely Leslie Tucker principal thank you design group which held.
You know do some work to bare back Leslie I want to start with you and ask you what is so unique about -- I mean it is old company and its aspirin what's unique about the -- Well I think what's unique about the brand -- the fact that there.
Represents many different kinds of formulas they're known for pain and prevention so under one umbrella brand company.
They actually take care people's hurt as well as asked for -- -- for their heart health.
-- what is it about the Tylenol brand that has made it so superior missiles space -- tunnel was that was the first aspirin free product hit the market it's -- a household name since -- early 1960s.
And frankly been related as a gentler pain relief product for only just.
-- -- going back to bear they lost a patent and patent rent out a long time ago for aspirin.
How have -- been able to compete in what kind of pressure of the generic competition for you know -- -- providing to them right now.
Well -- generics we call in store brands are basically number one and number two in practically every category that we buy so obviously they're gonna pose a problem to everyone.
But what happens when these kinds of products -- -- the market that launches.
Management and that there happened to look for new product formulas as well as new marketing approaches and new branding approaches and that's what we come.
You actually -- they'd come all the to scientific part of it but you guys helped sell to the public exactly through visual imagery that people see on the shelf and on TV.
And yet still to come because of price point though still the generics outsells.
-- yes they do and they are number one in the analgesic category.
-- thought about how long it obviously looked really -- there in 1982 with the Tylenol scare they've made -- major compact comeback since then.
How did they do it wouldn't step by -- ways that they were able really.
Erase that from the public's mind what they what they really did -- he really stayed true to their brand mission which is to be responsible for consumers employees.
The communities that they work in live.
And -- is those the first step was really assuming responsibility in the public -- And -- it allowed them to begin become the recovery process until fully restore confidence and become the number one product again.
And in other company played a role that I know we did not okay but you help them right now the continuing that effort.
We we are branding firm that I -- -- -- -- -- -- Okay Leslie speaking of branding.
-- you know people still let me say it's sort of like you know when you people -- attention they'll -- didn't Kleenex and the people wanted to ask for the most part they say I need a -- How do you guys keep that going in the public's mind that image that aspirin is -- Well I think what it is is that you know of course private label was -- encroaching on their territory so what we did release restates the brand about a year ago.
With that we brought up front and center that they -- cross which was the Criss -- their logo.
On the actual tablet we put that on the actual front panel of the of the box.
And that branded bear beyond just the concept of aspirin which is known to be -- a private label work now.
What about this -- to that taking a bear every day helps you prevent heart disease or helps you fight against heart disease that must be a boon for years were from there.
Yet that they basically helped response them into the adult market and also.
The fact that there is many different kinds of ingredients all rolled into one they are and anti inflammatory and analgesic.
And an anti coagulant so when the FDA gave them permission to market themselves as aspirin regiment.
Then it really -- launched and gave a new for the birth to -- -- -- name.
Right well let's talk about the emergence of bill leaving them -- term than those type of things how have they impacted.
And change the landscape in this place we really see that is it's created confusion to in the marketplace for a cantata I've confuse them.
Consumers don't know -- don't know what the differences are between products anymore in.
Frankly what we see is they go back to the brands that they trust.
So but I mean by walk into the AFC BS whatever I typically grabbed the first when -- -- although they do have specific differences between -- Whether what we're seeing as consumers will go back to a brand that they trust something that their mother give them something or they've given to their children to their gonna.
They're gonna lead themselves to town halls of the world because -- politicking -- exactly and get.
When -- -- you guys we have about a minute left start with you Roy.
What are the changes for the next two years in the space.
What we're seeing is is really kind of -- -- innovation.
-- expansion of products and in brand lines and down hopefully we're gonna get -- we're focused products out there to really kind of target.
-- Today Bayer aspirin stands for pain relief and heart attack prevention.
And tomorrow what we see is that -- -- scientists are studying the potential for aspirin to help against certain diseases like cancers and alzheimer's.
Also an aspirin a day -- for heart disease but may be against cancer and everything else one day not yet FDA approved but that's where they're going because they know that aspirin is the most -- wonder drug and work.
Okay Leslie appreciate it would appreciate it as well a couple of.
Filter by section